|
A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) Clinical research trials and A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL). A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) clinical trial. Participants typically obtain the most effective healthcare available for their A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)  A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
For Condition: Leukemia,Leukemia, Lymphocytic, Chronic
Status: Recruiting
Sponsor(s): Pharmacyclics ,
Synopsis: The purpose of this study is to determine if the drug motexafin gadolinium will be an effective treatment for patients who have chronic lymphocytic leukemia (CLL) that has come back after treatment or that has stopped responding to treatment.
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - At least 18 years old - Refractory or relapsed CLL - ECOG performance status score of 0, 1, or 2 - Each patient must sign a study-specific informed consent form Exclusion Criteria: Laboratory values of: - Platelet count <30,000/uL - AST or ALT >2 x the upper limit of normal (ULN) - Total bilirubin >2 x ULN - Creatinine >2.0 mg/dL - Chemotherapy, radiation therapy, immunotherapy, systemic corticosteroids, or systemic biologic anticancer therapy within 21 days before beginning study treatment - Women who are pregnant or lactating
Total Enrollment: 27
Location and Contact Information:
Ohio State University Medical Center *Recruiting*
Columbus, Ohio,
United States
Recruiting
Additional Information:
Study ID Numbers: PCYC-0216;
Study Start Date:
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00076401
Other Leukemia, Lymphocytic, Chronic Studies:
1. Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer
2. Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer
3. Blood and Marrow Transplant Clinical Research Network
4. Phase II Liposomal Vincristine for Pediatric and Adolescent Patients with Relapsed Malignancies
5. Cord Blood Stem Cell Transplantation Study (COBLT)
Related Studies:
Other Leukemia, Lymphocytic, Chronic Clinical Trials
Other Ohio Clinical Trials
Other Columbus Clinical Trials
A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
|
|
|
|
|
|
|
|
